Literature DB >> 19681804

Subtypes of major depression in substance dependence.

Mark J Niciu1, Grace Chan, Joel Gelernter, Albert J Arias, Kara Douglas, Roger Weiss, Raymond F Anton, Lindsay Farrer, Joseph F Cubells, Henry R Kranzler.   

Abstract

AIMS: This study evaluated features that differentiate subtypes of major depressive episode (MDE) in the context of substance dependence (SD). Design  Secondary data analysis using pooled data from family-based and case-control genetic studies of SD.
SETTING: Community recruitment through academic medical centers. PARTICIPANTS: A total of 1929 unrelated subjects with alcohol and/or drug dependence. MEASUREMENTS: Demographics, diagnostic criteria for psychiatric and substance use disorders and related clinical features were obtained using the Semi-Structured Assessment for Drug Dependence and Alcoholism. We compared four groups: no life-time MDE (no MDE), independent MDE only (I-MDE), substance-induced MDE only (SI-MDE) and both types of MDE.
FINDINGS: Psychiatric measures were better predictors of MDE subtype than substance-related or socio-demographic ones. Subjects with both types of MDE reported more life-time depressive symptoms and comorbid anxiety disorders and were more likely to have attempted suicide than subjects with I-MDE or SI-MDE. Subjects with both types of MDE, like those with I-MDE, were also more likely than subjects with SI-MDE to be alcohol-dependent only than either drug-dependent only or both alcohol- and drug-dependent.
CONCLUSIONS: SD individuals with both types of MDE have greater psychiatric severity than those with I-MDE only or SI-MDE only. These and other features that distinguish among the MDE subtypes have important diagnostic and potential therapeutic implications.
© 2009 The Authors. Journal compilation © 2009 Society for the Study of Addiction.

Entities:  

Mesh:

Year:  2009        PMID: 19681804      PMCID: PMC2980795          DOI: 10.1111/j.1360-0443.2009.02672.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  34 in total

1.  Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: contribution of antisocial personality disorder in men.

Authors:  Qiang Fu; Andrew C Heath; Kathleen K Bucholz; Elliot Nelson; Jack Goldberg; Michael J Lyons; William R True; Theodore Jacob; Ming T Tsuang; Seth A Eisen
Journal:  Arch Gen Psychiatry       Date:  2002-12

2.  Genetic risk factors for major depression in men and women: similar or different heritabilities and same or partly distinct genes?

Authors:  K S Kendler; C O Gardner; M C Neale; C A Prescott
Journal:  Psychol Med       Date:  2001-05       Impact factor: 7.723

3.  Alcoholism, anxiety and depression.

Authors:  M A Schuckit; M G Monteiro
Journal:  Br J Addict       Date:  1988-12

4.  Sex differences in rates of depression: cross-national perspectives.

Authors:  M M Weissman; R Bland; P R Joyce; S Newman; J E Wells; H U Wittchen
Journal:  J Affect Disord       Date:  1993 Oct-Nov       Impact factor: 4.839

5.  Effects of major depression on remission and relapse of substance dependence.

Authors:  Deborah Hasin; Xinhua Liu; Edward Nunes; Steven McCloud; Sharon Samet; Jean Endicott
Journal:  Arch Gen Psychiatry       Date:  2002-04

6.  The clinical implications of primary diagnostic groups among alcoholics.

Authors:  M A Schuckit
Journal:  Arch Gen Psychiatry       Date:  1985-11

7.  Primary depressives with secondary alcoholism compared with alcoholics and depressives.

Authors:  E Leibenluft; P A Madden; S E Dick; N E Rosenthal
Journal:  Compr Psychiatry       Date:  1993 Mar-Apr       Impact factor: 3.735

8.  Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; Mary C Dufour; Wilson Compton; Roger P Pickering; Kenneth Kaplan
Journal:  Arch Gen Psychiatry       Date:  2004-08

9.  Racial/ethnic differences in rates of depression among preretirement adults.

Authors:  Dorothy D Dunlop; Jing Song; John S Lyons; Larry M Manheim; Rowland W Chang
Journal:  Am J Public Health       Date:  2003-11       Impact factor: 9.308

10.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

View more
  5 in total

1.  Agitated depression in substance dependence.

Authors:  Adam M Leventhal; Joel Gelernter; David Oslin; Raymond F Anton; Lindsay A Farrer; Henry R Kranzler
Journal:  Drug Alcohol Depend       Date:  2011-01-31       Impact factor: 4.492

2.  A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers.

Authors:  Elias Dakwar; Edward V Nunes; Adam Bisaga; Kenneth C Carpenter; John P Mariani; Maria A Sullivan; Wilfrid N Raby; Frances R Levin
Journal:  Am J Addict       Date:  2011-07-11

Review 3.  Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?

Authors:  Mark J Niciu; Ioline D Henter; Gerard Sanacora; Carlos A Zarate
Journal:  World J Biol Psychiatry       Date:  2013-09-12       Impact factor: 4.132

4.  Variation in NGFB is associated with primary affective disorders in women.

Authors:  Donghong Cui; Huiping Zhang; Bao-Zhu Yang; Jennifer B Listman; Dawei Li; Lawrence H Price; Linda L Carpenter; Audrey R Tyrka; Raymond F Anton; Henry R Kranzler; Joel Gelernter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-02-03       Impact factor: 3.568

5.  A CRHR1 haplotype moderates the effect of adverse childhood experiences on lifetime risk of major depressive episode in African-American women.

Authors:  Henry R Kranzler; Richard Feinn; Elliot C Nelson; Jonathan Covault; Raymond F Anton; Lindsay Farrer; Joel Gelernter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-10-13       Impact factor: 3.568

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.